|
注册号: Registration number: |
ChiCTR-TRC-10001062 |
|
最近更新日期: Date of Last Refreshed on: |
2015-07-03 16:47:12 |
|
注册时间: Date of Registration: |
2010-10-27 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
牙周基础治疗对2型糖尿病患者牙周炎症控制及代谢水平的影响 |
|
Public title: |
Effects of non-surgical periodontal treatment on clinical, immunological responses and metabolic control in type 2 diabetic patients: a randomized study |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
牙周基础治疗对2型糖尿病患者牙周炎症控制及代谢水平的影响 |
|
Scientific title: |
Relationship between periodontal inflammaton and systemic diseases |
|
研究课题代号(代码): Study subject ID: |
2007 BAI 18 B 02 |
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
陈蕾 |
研究负责人: |
章锦才 |
|
Applicant: |
Lei Chen |
Study leader: |
Jincai Zhang |
|
申请注册联系人电话: Applicant telephone: |
+86 13660087016 |
研究负责人电话:
Study leader's |
+86 20 8441 3940 |
|
申请注册联系人传真 : Applicant Fax: |
+86 20 8443 3177 |
研究负责人传真: Study leader's fax: |
+86 20 8443 3177 |
|
申请注册联系人电子邮件: Applicant E-mail: |
13660087016@163.com |
研究负责人电子邮件: Study leader's E-mail: |
Jincaizhang@live.net |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
http://www.e5421.com/program/index.php?lang=cn |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
http://www.e5421.com/program/index.php?lang=cn |
|
申请注册联系人通讯地址: |
广州市海珠区江南大道南366号 广东省口腔医院 |
研究负责人通讯地址: |
广州市海珠区江南大道南366号 广东省口腔医院 |
|
Applicant address: |
366 Jiangnan Boulevard, Guangzhou, Guangdong, China |
Study leader's address: |
366 Jiangnan Boulevard, Guangzhou, Guangdong, China |
|
申请注册联系人邮政编码: Applicant postcode: |
510280 |
研究负责人邮政编码: Study leader's postcode: |
510280 |
|
申请人所在单位: |
广东省口腔医院 |
||
|
Applicant's institution: |
Guangdong Provincial Stomatological Hospital |
||
|
研究负责人所在单位: |
|
||
|
Affiliation of the Leader: |
|
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
IRB00001052-08010 |
伦理委员会批件附件: Approved file of Ethical Committee: |
|
|
批准本研究的伦理委员会名称: |
北京大学医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of Peking University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2008-02-28 00:00:00 | ||
|
伦理委员会联系人: |
|
||
|
Contact Name of the ethic committee: |
|
||
|
伦理委员会联系地址: |
|
||
|
Contact Address of the ethic committee: |
|
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
广东省口腔医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Peking University, Guangdong Provincial Stomatological Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
广州市海珠区江南大道南366号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
366 Jiangnan Boulevard, Guangzhou, Guangdong, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
十一五国家支撑计划专项基金 |
||||||||||||||||||||||
|
Source(s) of funding: |
Key Projects in the National Science & Technology Pillar Program in the Eleventh Five-Year Plan Periods |
||||||||||||||||||||||
|
研究疾病: |
糖尿病性牙周病 |
||||||||||||||||||||||
|
Target disease: |
diabetic parients with periodontitis |
||||||||||||||||||||||
|
研究疾病代码: |
E14.604 |
||||||||||||||||||||||
|
Target disease code: |
E14.604 |
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
(1) 社区服务模式下的牙周干预策略对2型糖尿病患者牙周局部炎症控制,血糖、血脂代谢水平,以及机体炎症状态的影响; (2) 比较两种牙周维护方法(预防性龈上洁治vs龈下刮治)对伴2型糖尿病牙周炎患者的疗效 |
||||||||||||||||||||||
|
Objectives of Study: |
(1) to evaluate effects of non-surgical periodontal treatment on clinical response, metabolic control (including glycemic and lipid metabolism) and systemic inflammatory level in patients with type 2 diabetes; (2) to explore effectiveness of supragingival prophylaxis vs that of subgingival debridement for supportive periodontal care following the treatment of chronic periodontitis in type 2 diabetes. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
ⅰ患有影响牙周健康的其他系统性疾病,如冠心病等; |
||||||||||||||||||||||
|
Exclusion criteria: |
1. presence of systemic diseases other than DM that influence the course of periodontal disease; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2008-09-01 00:00:00至 To 2009-10-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2008-09-01 00:00:00 至 To 2009-03-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
结束 /Completed |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
计算机软件 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
computer software |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
治疗者 否 不可能对治疗人员实施盲法 研究对象 否 患者很清楚自己是否接受了牙周治疗 检查者 否 检查者很清楚患者是否接受了牙周治疗 |
|
Blinding: |
Therapist: not subjects: not outcome examiner: not |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
|
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
广东省口腔医院 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Guangdong Provincial Stomatological Hospital |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
南方医科大学统计教研室 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Southern Medical University |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |